+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Recent multidisciplinary approach with molecular targeted drugs for advanced head and neck cancer



Recent multidisciplinary approach with molecular targeted drugs for advanced head and neck cancer



International Journal of Clinical Oncology 19(2): 220-229



The multidisciplinary approach is becoming the standard for treatment of advanced head and neck cancer. Combined modality treatment preserves quality of life as well as improving the length of survival time. Molecular targeted drugs have become very important in the multidisciplinary approach for the treatment of advanced head and neck cancer. Cetuximab has been shown to have locoregional control and additional survival benefits in locally advanced squamous cell carcinoma of the head and neck as well as additional survival benefits in distant metastatic/recurrent squamous cell carcinoma of the head and neck. Recently, many clinical studies of the multidisciplinary approach including cetuximab have been carried out in Europe and the US. It has been shown that cetuximab in combination with radiotherapy (RT) is significantly superior to the RT alone in median locoregional control duration and median overall survival (OS). For recurrent or metastatic disease, the results of a phase III randomized control study of CDDP + 5-fluorouracil combination therapy with or without cetuximab reported that OS was significantly longer with than without cetuximab, demonstrating an additional survival benefit of cetuximab. Many trials including induction chemotherapy are being conducted. Clinical trials with cetuximab have also been conducted in Japan. Though combination with cetuximab shows some benefit, further studies are necessary to obtain the standard treatments for a multidisciplinary approach for advanced head and neck cancer.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 055401549

Download citation: RISBibTeXText

PMID: 24578179

DOI: 10.1007/s10147-014-0671-9


Related references

Recent advances in molecular-targeted drugs in head and neck cancer. Gan to Kagaku Ryoho. Cancer & ChemoTherapy 35(5): 745-752, 2008

Role of chemotherapy in the multidisciplinary approach to advanced head and neck cancer: potentials and problems. Annals of Otology, Rhinology, and Laryngology 90(5 Pt 1): 506-511, 1981

A multidisciplinary therapeutic approach for advanced previously untreated epidermoid cancer of the head and neck: preliminary report. International Journal of Radiation Oncology, Biology, Physics 5(8): 1421-1423, 1979

Molecular targeted therapies in head and neck cancer--an update of recent developments-. Head & Neck Oncology 2: 8-8, 2010

The role of the head and neck surgeon in contemporary multidisciplinary treatment programs for advanced head and neck cancer. Current Opinion in Otolaryngology & Head and Neck Surgery 18(2): 79-82, 2010

Recent advances in head and neck cancer therapy: the role of new cytotoxic and molecular-targeted agents. Current Opinion in Oncology 18(3): 247-252, 2006

A multidisciplinary approach to head and neck cancer. European Journal of Cancer Care 7(2): 93-96, 1998

Head and neck cancer A multidisciplinary approach. Harrison, L B , Sessions, R B , Hong, W K Head and neck cancer: A multidisciplinary approach xx+1096p, 1999

Efficacy of targeted chemoradiation and planned selective neck dissection to control bulky nodal disease in advanced head and neck cancer. Archives of Otolaryngology--Head & Neck Surgery 125(6): 670-675, 1999

Multidisciplinary approach for the treatment of head and neck cancer. International Journal of Clinical Oncology 19(2): 209-210, 2014

The challenging integration of platinum compounds, taxanes, and molecular-targeted therapies in the multidisciplinary treatment of squamous cell carcinoma of the head and neck. Current Opinion in Oncology 19(3): 177-179, 2007

Laryngeal preservation in head and neck cancer: multidisciplinary approach. Lancet. Oncology 7(9): 747-755, 2006

Multidisciplinary clinical approach to the management of head and neck cancer. European Archives of Oto-Rhino-Laryngology 269(12): 2451-2454, 2013

Unknown primary cancer of the head and neck: a multidisciplinary approach. Clinical & Translational Oncology 13(2): 88-97, 2011

Multidisciplinary approach to cancer treatment: focus on head and neck cancer. Dental Clinics of North America 52(1): 1-17, Vii, 2007